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I
n chronic kidney disease (CKD), fatigue is reported as the most prevalent and severe symptom experienced by patients. [1] [2] [3] Such fatigue has been identified as the principal factor influencing quality of life in this population, 2, 4, 5 and fatigue also impacts on mortality. 6 However, fatigue is poorly investigated, diagnosed, and treated in patients with CKD.
Scientific investigations in this area lack a precise definition of fatigue. Fatigue is recognized to be multidimensional in nature and consists of various subtypes, each of which may have distinct mechanisms. 7 It has been advocated that explanatory studies of specific fatigue subtypes are needed to clarify pathophysiology in relation to phenomenology. 7 One subtype of fatigue is exertional fatigue, defined as an increased sense of effort in relation to a task. 8 This subtype can be measured easily during physical tasks using the extensively validated rating of perceived exertion (RPE) scale. 9 By simulating normal activities of daily living and simultaneously obtaining measurements of RPE, it becomes possible to define and measure a specific construct of fatigue of particular relevance to quality of life. 10 In addition to problems defining fatigue, the exact cause of fatigue in patients with CKD is unknown. One potential mechanism is an altered oxygen transport chain 11, 12 ; oxygen delivery and/or oxygen utilization may be impaired in patients with CKD. 13 In this
From the 1 College of Health and Behavioural Sciences, Bangor University; regard, it increasingly is being recognized that oxygen utilization has a relatively minor role in CKD myopathy and fatigue, evidenced by elegant studies showing normal mitochondrial function. [14] [15] [16] [17] In contrast, oxygen convection (from the lung to the muscle capillary) and specifically anemia are commonly cited causes of general fatigue in patients with CKD. 18 More recently, it has been advocated that anemia treatment be targeted by patient-reported fatigue, although the optimal hemoglobin target is unclear. 19 Furthermore, the influence of mild anemia on exertional fatigue is ambiguous because when healthy persons are made anemic experimentally, they compensate to maintain oxygen delivery (eg, by elevating cardiac output), especially at lower exercise intensities, as typically experienced during activities of daily living. [20] [21] [22] Experimental evidence contradicting a primary role of mild anemia in fatigue also is provided by the surprisingly minor impact of erythropoietin therapy on this symptom. 23, 24 Thus, some authors have concluded that oxygen conductance (muscle capillary to mitochondria) is of greater importance than oxygen convection/anemia. 25 Still, previous studies must be interpreted cautiously. These studies often investigated maximal 26 and single-leg 27 exercise paradigms, but submaximal exercise and whole-body exercise better simulate activities of daily living. When submaximal comparisons have been made, exercise intensities relative to participants' maximal exercise capacity often have been used, 25 making interpretation of oxygen delivery and utilization variables difficult due to different absolute exercise intensities. Furthermore, most studies focus on hemodialysis patients, although this subgroup makes up only a small fraction of patients with CKD. 28 Whether fatigue also occurs in patients with moderate CKD is underinvestigated, and whether such patients with CKD adapt to reduced oxygen delivery is unknown, making guidelines for how to treat conditions such as exertional fatigue and anemia difficult to offer. 29 Therefore, the aim of this study was to determine whether exertional fatigue, assessed by RPE, is elevated in patients with CKD during simulated activities of daily living. A secondary aim was to determine the role of oxygen delivery and utilization in exertional fatigue, investigating whole-body, submaximal, and absolute exercise intensities to better represent activities of daily living. We hypothesized that exertional fatigue, assessed by RPE, would be increased in patients with CKD during submaximal exercise. Furthermore, we hypothesized that oxygen convection/ anemia would be involved minimally in such elevated exertional fatigue due to cardiac compensation maintaining oxygen delivery, thus suggesting that other factors (such as poor oxygen conductance from muscle capillary to mitochondria) are of greater importance to exertional fatigue in patients with CKD. 30 from 2 serum samples at least 3 months apart. Exclusion criteria for controls were current CKD stages 1-5 and medications that elicit abnormal physiologic responses to exercise (eg, ␤-blockers). Exclusion criteria for both groups were age younger than 18 years, history of renal replacement therapy or acute kidney injury, any uncontrolled metabolic condition (eg, gross obesity or uncontrolled diabetes), pulmonary or neuromuscular disease, hemoglobin concentration Ͻ11 g/dL, and not being able to self-ambulate for 50 m.
METHODS

Patients and Study Design
After written informed consent, all participants presented at the School of Sport, Health and Exercise Sciences between January 2008 and July 2010 for testing procedures. All participants attended for testing on 2 occasions: visit 1 was to familiarize participants with the protocol and use of the RPE scale, and visit 2 was identical to visit 1 and was completed 7 days later. Data from visit 2 were used for analysis. Participants abstained from alcohol, caffeine, and strenuous exercise for 24 hours prior to appointments, then consumed a standard light meal and water 2 hours prior to arrival.
Assessment of Participant Characteristics and Psychological Outcomes
Height, body mass, and body composition were measured using a wall-mounted stadiometer and bioelectrical impedance analyzer (TBF300MA; Tanita, www.tanita.co.uk). Physical activity level was assessed by 7-day pedometer counts (Digi-Walker SW-200; Yamax, www.yamax.co.uk). Cause of CKD was classified as previously described. 31 To provide a general overview of quality of life including fatigue, version 2 of the UK (English) Short Form Health Survey 36 (SF-36) was selected. 32 This survey is a UK English translation of version 2 of the US (English) SF-36. The Vitality subscale was of particular interest and is presented herein. To provide a measure of chronic illness-associated fatigue, the Functional Assessment of Chronic Illness Therapy-Fatigue (FACITFatigue) subscale was selected due to good face validity to assess anemia-related fatigue. 33 To determine whether affect may have influenced these measures, the 20-item Positive and Negative Affect Schedule (PANAS) was used to assess positive (the degree to which the individual feels enthusiastic and alert) and negative affect (the degree to which the individual feels aversive mood states and general distress) during the preceding week. 34, 35 Participants then were familiarized with the 15-point 6-20 RPE scale 9 using the provided standard written instructions and appropriate anchoring. Points 6, 13, and 20 equated to verbal descriptors of "no exertion at all," "somewhat hard," and "maximal exertion," respectively.
Assessment of Physiologic Outcomes
Exercise testing consisted of submaximal cycle ergometer exercise (Corival; Lode, www.lode.nl) with progressively increasing intensity. After measurements at rest, participants cycled at 60 rpm and 0 W, then intensity was increased by 25 W every 3 minutes to a maximum of 150 W or heart rate of 75% of predicted maximum (calculated as 220 Ϫ age). Only the 3 lowest exercise intensities were completed by all participants and hence their inclusion here. These intensities were selected to represent the energy expenditure of typical activities of daily living. 36 In this sample, intensities represented: at rest, 1.00 Ϯ 0.33 metabolic equivalent tasks (METs; eg, sitting quietly); 0 W, 1.84 Ϯ 0.55 METs (eg, ironing); 25 W, 2.38 Ϯ 0.52 METs (eg, food shopping); and 50 W, 3.10 Ϯ 0.68 METs (eg, putting away household items), in which 1 MET represents the ratio of work metabolic rate to the metabolic rate at rest or oxygen uptake of 3.5 mL/kg/min. 36 In the last 30 seconds at each intensity, RPE was recorded and outcome measurements were averaged and obtained. Minute ventilation, oxygen uptake (consumption), carbon dioxide production, and respiratory exchange ratio were measured/calculated by an automated gas analyzer (Metalyser 3B; Cortex, www.cortexmedical.de). Heart rate, stroke volume, cardiac output (Q ), blood pressure, and total peripheral resistance were obtained by integrating a thoracic bioimpedance analyzer (Physioflow; Manatec, www. physioflow.com) and an automated blood pressure monitor (Tango; SunTech Biomedical, www.suntechmed.com). The validity of Q estimations using this thoracic bioimpedance analyzer has been shown against the direct Fick method during submaximal cycling exercise. 37 Arterial oxygen saturation (SpO 2 ) was determined by fingertip pulse oximetry (Onix 9500; Nonin, www.nonin.com). Blood outcome measurements were obtained from arterialized blood collected from the earlobe after topical application of a vasodilating agent (Finalgon cream; Boehringer Pharma, www. boehringer-ingelheim.co.uk). Blood lactate and hemoglobin concentrations were determined by handheld lactate analyzer (Lactate Pro LT1710; Akray, www.arkray.co.jp) and desktop photometer (HemoCue Ltd, www.hemocue.com). Using the measures described, mean arterial blood pressure, total systemic peripheral resistance, blood oxygen-carrying capacity, whole-body oxygen delivery, and whole-body oxygen extraction ratio were calculated using the equations shown in Box 1. 38 Leg muscle deoxygenation was determined continuously by spatially resolved spectroscopy of the nondominant leg in the vastus lateralis. The deoxygenated hemoglobin signal is dependent on changes in oxygen extraction and generally is independent of blood perfusion. 39 After determination of subcutaneous fat depth, an adhesive probe of a continuous wave near-infrared spectroscopy instrument (Nimo; Nirox, www.nirox.it) was placed on the skin 15 cm above the proximal border of the patella and 5 cm lateral to the midline of the thigh. The validity of this technique has been shown previously for patient populations, 40 whereas the reliability of this technique in our laboratory ranged from good (eg, coefficient of variation of deoxygenated hemoglobin is 4.8% at 100 W) to adequate (coefficient of variation of deoxygenated hemoglobin at rest is 10.2%), tested on 10 healthy people 1 week apart.
Statistical Analyses
All data are presented as mean Ϯ standard deviation. All statistical analyses were completed using SPSS, version 18 (IBM Corp, www.ibm.com) and statistical significance was accepted at P Յ 0.05. After checking and correcting for relevant assumptions, 41 2-tailed independent-sample t tests were used to compare demographic and psychological assessment data and also psychophysiologic data obtained at rest. Analyses of variance were used to compare data obtained during the incremental test with a between factor of group (patient and control) and a repeatedmeasures factor of intensity (1.8, 2.4, and 3.1 METs). Significant main effects and interactions were followed up with Tukey tests or stepdown Holm-Bonferroni tests, as appropriate. 41, 42 For the main outcome measure of RPE, effect size (eta squared,
2 ) also was used to describe the proportion of the total variability in RPE attributable to group allocation, where 0.01 is small, 0.06 is medium, and 0.14 is large effects. 43 This study was powered to test the hypothesis that exertional fatigue, assessed by RPE, would be increased in patients with CKD during submaximal exercise. During the incremental exercise test, a significant main effect of group (patient vs control) by analysis of variance would provide support for the hypothesis. Using the tables of Bausell and Li 44 (2002) , 12 participants per group would result in an 80% chance of obtaining statistical significance through the main effect of group. Effect size was estimated to be 1.2, calculated from a study using a protocol similar to ours in patients with chronic fatigue syndrome, whereby reported RPE values were 0.16 per watt in patients and 0.10 per watt in controls (pooled SD ϭ 0.05).
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RESULTS
Participant Characteristics
Recruitment and participation are shown in Fig 1 . Mean eGFR in the patient group was 29 Ϯ 10 mL/min/ 1.73 m 2 ; 5 patients were in stage 3b and 8 patients were in stage 4 CKD. Causes of CKD were arteriopathic (n ϭ 1), diabetic (n ϭ 3), infective/obstructive (n ϭ 1), systemic (n ϭ 1), and uncertain (n ϭ 7). Mean values for all other clinical data and blood variables were within the ranges recommended by the Renal Association Standard (data not shown). Seven patients were prescribed an angiotensin-converting enzyme inhibitor; 1 patient, an angiotensin II receptor antagonist; 5 patients, ␤-blockers; 2 patients, an ␣-blocker; 4 patients, a calcium channel blocker; 5 patients, a lipid-lowering agent; 6 patients, a diuretic; and 5 patients, erythropoietin. Of the controls, 2 were hospital staff, 2 were friends of patients, and 9 were from local clubs and societies (eg, Rotary Club and Women's Institute). No participants were current smokers.
Matching of patients to controls was successful, with no significant differences between groups for Abbreviations and definitions: CaO 2 , blood oxygen-carrying capacity; DBP, diastolic blood pressure; DO 2 , whole-body oxygen delivery; Hb, hemoglobin; MAP, mean arterial pressure; O 2 ER, whole-body oxygen extraction ratio; Q , cardiac output; SBP, systolic blood pressure; SpO 2 , arterial oxygen saturation; T s P r , total systemic peripheral resistance; VO 2 , oxygen uptake.
sex, age, height, body mass and composition, and physical activity level (Table 1 , top half). Psychological measurements of fatigue were significantly elevated in patients compared with controls (Table 1 , bottom half). Patients also had significantly lower scores of positive affect, suggesting that patients were less enthusiastic and alert than controls.
Psychophysiologic Outcomes
At rest (1 MET; Table 2 ), most psychophysiologic outcomes were similar in patients and controls (P ϭ 0.1-0.9 by t test). Exceptions included hemoglobin concentration (P ϭ 0.001), arterial oxygen content (P ϭ 0.005), and whole-body oxygen delivery (patients vs controls: 1,016 vs 1,249 mL/min of oxygen; P ϭ 0.05), which were all decreased in patients despite increased arterial oxygen saturation (P ϭ 0.002).
During the incremental exercise test, the main outcome measure of RPE was greater in patients than in controls, being significantly elevated in patients at 1.8 METs by 1 scale point and at 2.4 and 3.1 METs by approximately 2 scale points (Fig 2) . This elevation equated to a subjective descriptor increase in patients at 2.4 METs (eg, food shopping) from very light to light and at 3.1 METs (eg, putting away household items) from light to somewhat hard.
Significantly elevated blood lactate production at 2.4 and 3.1 METs (Fig 3) and significantly decreased oxygen uptake at 2.4 and 3.1 METs (Table 2) , combined with a significantly increased respiratory exchange ratio throughout the incremental test ( revealed a greater reliance on anaerobic glycolysis in patients compared with controls. Of the central physiologic factors that potentially could explain this phenomena, arterial oxygen content was significantly decreased in patients due to a significantly and substantially (ϳ25%) decreased hemoglobin concentration (Table 2 ). This decrease outweighed a significant but minor (ϳ2%) elevation in patients' SpO 2 (Table 2) . Furthermore, similar heart rate, stroke volume, and consequently cardiac output response in patients (Table  2 ) resulted in significantly reduced whole-body oxygen delivery (Fig 4) . Further contributing to increased reliance on anaerobic glycolysis, at the periphery, patients did not increase oxygen extraction. This was confirmed by both methods of determination: first at the wholebody level (oxygen extraction ratio, Table 2 ) and again in the vastus lateralis, evidenced by nearinfrared spectroscopy. Specifically, the deoxygenated hemoglobin signal showed no difference in response between patients and controls (analysis of variance group effect, P ϭ 0.8; interaction effect, P ϭ 0.5), instead showing in both groups an expected transient decrease on initiation of exercise followed by a gradual increase as exercise intensity increased (combined group mean values at 1 MET, 18 Ϯ 13 M; at 1.8 METs, 14 Ϯ 11 M; at 2.4 METs, 15 Ϯ 11 M; and at 3.1 METs, 16 Ϯ 12 M).
DISCUSSION
This study shows that exertional fatigue is present in patients with moderate CKD. Specifically, patients with CKD stages 3b and 4 reported increased RPE during simulated activities of daily living. Patients with CKD had a greater contribution to energy production from anaerobic sources, consistent with a mechanism of altered oxygen delivery. However, contrary to our hypotheses, patients with CKD did not compensate for mild anemia by increasing cardiac output and did not increase oxygen extraction, suggesting that compensatory mechanisms in the oxygen transport chain failed to address decreased arterial oxygen content. Thus, these data are consistent with both an oxygen convective (lung to muscle capillary) and oxygen conductive (capillary to mitochondria) defect in CKD.
This study investigated exertional fatigue at exercise intensities designed to represent activities of daily living, such as ironing, food shopping, and putting away household items. 36 Similar study designs have been used in other diseases, including chronic fatigue syndrome. 10 Consistent with these studies and with multidimensional measurements of fatigue obtained in patients with CKD, 18 RPE successfully discriminated between fatigued patients with CKD and nonfatigued healthy controls. Thus, RPE seems to be a valid measure of exertional fatigue. Various potential physiologic parameters have been hypothesized to explain such increased fatigue in patients with CKD. 18 Uniquely, RPE measurement allows the simultaneous assessment of these physiologic parameters and of the specific construct of exertional fatigue, enabling enhanced exploration of fatigue's underlying mechanisms.
The increased anaerobic metabolism shown in the present data set is consistent with previous reports 45 and theoretically could be due to poor oxygen utilization. However, oxygen utilization (mitochondrial function) has been shown to be normal in patients with CKD, especially after accounting for confounding Note: Except where indicated, data are given as mean Ϯ standard deviation. Conversion factor for hemoglobin in mg/dL to mg/L, ϫ10.
Abbreviations: CaO 2 , arterial oxygen content; Ctrl, control; Hb, hemoglobin; MAP, mean arterial blood pressure; METs, metabolic equivalent tasks; O 2 ER, whole-body oxygen extraction; Pt, patient; SpO 2 , arterial oxygen saturation; T s P r , total systemic peripheral resistance; VCO 2 , carbon dioxide production; V E , minute ventilation; VO 2 , oxygen uptake.
a Statistical significance for interaction of group (patients vs controls) ϫ intensity ( [15] [16] [17] 46 Therefore, the present data for increased lactate production and respiratory exchange ratio are more likely due to altered oxygen delivery. A seminal study investigated oxygen delivery in patients with CKD using comprehensive invasive measures. 25 However, analysis of such data to establish the effect of anemia on oxygen delivery was hampered by the use of exercise intensities set relative to participants' maximal oxygen uptake, resulting in healthy controls exercising at much greater absolute power outputs than patients with CKD. Thus, any observed changes to oxygen delivery may have been due to different metabolic rates rather than a defect in the oxygen transport chain per se. Therefore, the present study provides important additional information concerning oxygen delivery. Even when exercising at the same absolute submaximal exercise intensity, as experienced during activities of daily living, whole-body oxygen delivery is decreased in patients with stages 3b and 4 CKD. If oxygen delivery is decreased, both leg and respiratory muscles will experience greater muscle fatigue, 12 which has been shown experimentally 11, 47 to increase RPE, as observed here. This finding is in contrast to induced anemia in healthy people. Reduced hemoglobin concentration normally increases limb blood flow, venous return, and sympathetic tone, resulting in elevated heart rate and stroke volume. 29, [48] [49] [50] Such a cardiac output increase, combined with blood flow redistribution 29 and biochemical changes, 29 ,51,52 maintains oxygen delivery sufficiently so that aerobic glycolysis is sustained and exertional effort (RPE) remains largely normal, at least during submaximal exercise intensities as observed during activities of daily living. 20, 21, 50 Whether chronically anemic patients with CKD adapt to decreased hemoglobin levels using similar mechanisms is poorly understood. 29 The present data suggest that patients with CKD adapt inadequately, with an insufficient increase in cardiac output that reduces oxygen convection, resulting in increased anaerobic glycolysis and ultimately increased exertional fatigue. In patients with CKD, cardiac control is altered 53, 54 and medications such as ␤-blockers blunt sympathetic stimulation, 29 potentially explaining the observed lack of central compensation. Blood flow redistribution and biochemical changes at muscle level also may be inadequate and are worthy of further investigation. 29, 51, 52 Patients also could have compensated for anemia and reduced oxygen delivery by increasing oxygen extraction. 50, 52 However, 3 sources of evidence in the present study suggest that oxygen extraction remained inappropriately normal. First, blood lactate level and respiratory exchange ratio were increased, showing that patients relied on anaerobic glycolysis rather than increased oxygen extraction to sustain aerobic glycolysis. Second, whole-body oxygen extraction ratio, calculated from whole-body oxygen uptake and oxygen delivery, was similar between patients and controls. Third, near-infrared spectroscopy measurements of deoxygenated hemoglobin in the vastus lateralis did not increase in patients compared with controls, indicative of unchanged oxygen extraction when directly assessed in the muscle. 39 Although the mechanism for the lack of increase in oxygen extraction was not specifically investigated in the present study, the data are consistent with previous research suggesting oxygen conductance from capillary to mitochondria is altered in CKD. 25 In this regard, the increased oxygen saturation present in patients with CKD is consistent with a leftward-shifted oxygen hemoglobin disassociation curve that would hamper oxygen unloading at the tissues. 50 Additionally, muscle wasting typical of this population 55 may reduce mitochondrial mass, further limiting oxygen extraction.
However, muscle wasting was not specifically investigated in the present study. Other limitations include lack of detailed analysis of psychological effects on fatigue. Positive affect was reduced in patients with CKD. In this matched-cohort study, use of a convenience sampling method may have selected less fatigued patients, underestimating fatigue severity. Also, the study did not include invasive assessments of cardiac output and limb metabolism, instead using techniques including RPE, impedance cardiac output assessment, and near-infrared spectroscopy. Nevertheless, these techniques have been validated in patient populations, 10, 37, 40 and the study offers novel outcome measures that could facilitate future fatigue research in CKD. Other study strengths include holistic assessment of patients during protocols relevant to activities of daily living, a well-controlled study design using group-matched healthy controls for parameters such as physical activity level, a laboratory setting, and a specific definition of fatigue to investigate this multidimensional symptom. 7 The present data fuel the debate on hemoglobin targets in CKD; although safety concerns may exist, the lack of compensation for anemia in the present study suggests that blood oxygen-carrying capacity could be increased to reduce exertional fatigue. To maximize benefits of increased hemoglobin levels, mechanisms resulting in a lack of compensation for anemia, which we speculate would include diminished cardiac function, reduced oxygen conductance, and muscle wasting, should be targeted. Exertional fatigue (RPE) also should be considered as an outcome measure in future fatigue intervention trials. 
